Kingdom Financial Group
RPRX icon

Kingdom Financial Group’s Royalty Pharma RPRX Stock Holding History

Kingdom Financial Group’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25.5K Sell
436
-56
-11% -$3.3K 0.01% 371
2026
Q2 		$27.6K Buy
+492
New +$25.6K 0.01% 330
2026
Q1 		– Sell
-436
Closed -$16.8K – 918
2025
Q4 		$16.8K Buy
+436
New +$16.6K 0.01% 367

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Kingdom Financial Group's RPRX Position: Q3 2026 in Review

Kingdom Financial Group reduced its Royalty Pharma (RPRX) stake by 11% in Q3 2026, selling an estimated $3.3K and leaving 436 shares worth $25.5K. The position accounts for 0.01% of the portfolio, ranked #371.

Kingdom Financial Group first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $27.6K in Q2 2026. 573 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Kingdom Financial Group held 436 shares of Royalty Pharma worth $25.5K as of Q3 2026.
  • Kingdom Financial Group sold 56 Royalty Pharma shares in Q3 2026, an estimated $3.3K.
  • Royalty Pharma made up 0.01% of Kingdom Financial Group's portfolio in Q3 2026, its #371 holding.
  • Kingdom Financial Group first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
  • Kingdom Financial Group's Royalty Pharma position peaked at $27.6K in Q2 2026.
  • 573 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Kingdom Financial Group's 13F filing for Q3 2026, filed 4 Nov 2026.